We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Journal Scan / Research · July 15, 2021

Effectiveness and Safety of Eribulin in Advanced or Metastatic Breast Cancer

Critical Reviews in Oncology / Hematology

 

Additional Info

Disclosure statements are available on the authors' profiles:

Critical Reviews in Oncology / Hematology
Comparative Effectiveness and Safety of Eribulin in Advanced or Metastatic Breast Cancer: A Systematic Review and Meta-Analysis
Crit. Rev. Oncol. Hematol 2021 Jul 01;163(xx)103375, KA Tanni, CB Truong, BS Johnson, J Qian

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading